Phase III randomized controlled trial of adjuvant capecitabine/cisplatin chemotherapy and chemoradiation therapy for gastric adenocarcinoma.
Phase of Trial: Phase III
Latest Information Update: 07 Jun 2016
At a glance
- Drugs Capecitabine (Primary) ; Cisplatin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- Acronyms ARTIST
- 19 Dec 2011 Results published in the Journal of Clinical Oncology.
- 19 Dec 2011 Primary endpoint 'Disease-free-survival-rate' has not been met.
- 08 Nov 2011 Actual end date Apr 2011 added as reported by ClinicalTrials.gov.